Comment Regarding "Comparative Effectiveness of Anti-TNF in Combination With Low-Dose Methotrexate vs Anti-TNF Monotherapy in Pediatric Crohn's Disease: A Pragmatic Randomized Trial"

被引:0
|
作者
Calderon, Lina Posada [1 ]
Strasser, Mary Oakley [1 ]
Brant, Aaron [1 ]
机构
[1] New York Presbyterian, Weill Cornell Med, Dept Urol, New York, NY 10032 USA
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:1306 / 1307
页数:2
相关论文
共 50 条
  • [41] Adalimumab as first-line anti-TNF treatment in pediatric Crohn's disease
    Martin-de-Carpi, J.
    Navas-Lopez, V. M.
    Navalon-Rubio, M.
    Llerena-Santa-Cruz, E.
    Gil-Ortega, D.
    Varea-Calderon, V.
    Sierra-Salinas, C.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S427 - S427
  • [42] Addition of thiopurine can recapture lost response to anti-TNF monotherapy in Crohn's disease
    Ong, David E.
    Lust, Mark
    Kamm, Michael A.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 : 113 - 113
  • [43] Addition of thiopurine can recapture lost response to anti-tnf monotherapy in Crohn's disease
    Ong, David
    Lust, Mark
    Kamm, Michael
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 : 158 - 158
  • [44] Anti-TNF therapies have eliminated the need for steroids in pediatric Crohn's disease
    Grand, RJ
    INFLAMMATORY BOWEL DISEASES, 2001, 7 (04) : 345 - 346
  • [45] Effectiveness of ustekinumab in fistulising perianal Crohn's disease refractory or intolerant to anti-TNF
    Carpio, D.
    Calvino-Suarez, C.
    Martinez-Cadilla, J.
    Molina, G.
    Vazquez-Rey, M. T.
    Marti, E.
    Fernandez-Salgado, E.
    Acosta, M. Barreiro-de
    Hernandez, V.
    Echarri, A.
    Diz-Lois, M. T.
    Baz, A.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S419 - S420
  • [46] Adalimumab as first-line anti-TNF treatment in pediatric Crohn's disease
    Martin-de-Carpi, J.
    Navas-Lopez, V. M.
    Navalon-Rubio, M.
    Llerena-Santa-Cruz, E.
    Gil-Ortega, D.
    Varea-Calderon, V.
    Sierra-Salinas, C.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S309 - S309
  • [47] Adalimumab As First-Line Anti-TNF Treatment in Pediatric Crohn's Disease
    Martin-de-Carpi, Javier
    Navas-Lopez, Victor
    Navalon-Rubio, Maria
    Llerena-Santa-Cruz, Enrique
    Ortega, David Gil
    Varea-Calderon, Vicente
    Sierra-Salinas, Carlos
    GASTROENTEROLOGY, 2014, 146 (05) : S780 - S780
  • [48] ANTI-TNF ALPHA THERAPY AND MUCOSAL HEALING IN A PEDIATRIC CROHN'S DISEASE POPULATION
    Nuti, F.
    Civitelli, F.
    Di Nardo, G.
    Bloise, S.
    Dilillo, A.
    Aloi, M.
    Viola, F.
    Cucchiara, S.
    DIGESTIVE AND LIVER DISEASE, 2014, 46 : S9 - S9
  • [49] Real-World Anti-TNF Dose Escalation in Patients With Crohn's Disease
    Rubin, David T.
    Kane, Sunanda
    Jaganathan, Srihari
    Palmer, Liisa
    Cyhaniuk, Anissa
    AMERICAN JOURNAL OF PHARMACY BENEFITS, 2015, 7 (05) : E135 - E140
  • [50] A Population-Based Study of Combination vs Monotherapy of Anti-TNF in Persons With IBD
    Elias, Evan D.
    Targownik, Laura E.
    Singh, Harminder
    Bernstein, Charles N.
    INFLAMMATORY BOWEL DISEASES, 2020, 26 (01) : 150 - 157